Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT03798769
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or older
* Within three weeks of signing consent for parent trial of neoadjuvant FOLFIRINOX
* Planning to receive care at Massachusetts General Hospital
* Ability to read and respond to questions in English
* Residing within 50 miles of Massachusetts General Hospital
Exclusion Criteria:
-Uncontrolled psychiatric illness or impaired cognition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03798769
Study Brief:
Protocol Section:
NCT03798769